Phase II Randomized, Multicenter Study of Lenalidomide Vs Best Investigator’s Choice in Relapsed/Refractory Mantle Cell Lymphoma: Results of the MCL-002 (SPRINT) Study
暂无分享,去创建一个
J. Radford | L. Arcaini | M. Trněný | J. Walewski | M. Patturajan | W. Jurczak | D. Belada | T. Lamy | J. Mayer | D. Osmanov | Julia Alexeeva | T. Biyukov | M. Bravo | Tsvetan Biyukov